SAPA-DC is excited to announce our 3rd annual conference on October 14th, 2018 at Foley & Lardner Washington DC office (waterfront venue at the Washington Harbour). This conference will focus on cross-nation pharmaceutical development and beyond, and we are bringing together executives from biotech and pharmaceutical companies in US and China, partners from top law firms, high-level regulatory officers, experienced health-tech investors and business professionals as speakers and panelists.
The conference will cover the following areas:End-to-end pharmaceutical development, Multi-regional clinical trials and regulatory affairs, Legal issues in drug development and commercialization, Payer and reimbursement environments in US and China,CEO forum, business development and VC/PE investment
This is an excellent opportunity for individuals to explore the industry, get updates about the latest trends and build personal & corporate connections as the conference will attract 200 high-caliber pharmaceutical executives and scientists, regulatory experts, legal practitioners, investors, scientific researchers and healthcare business professionals from US and China. For companies, this conference will be a perfect platform for talent recruitment, brand promotion, business development, project collaboration, and investment.